Oliver Ottmann, MD, FRCPath from Cardiff University, Cardiff, UK gives us an overview of four major topics covered at the 2017 European Hematology Association (EHA) annual congress in Madrid, Spain regarding acute myeloid leukemia (AML). Prof. Ottmann talks to us about the impact that these topics, including minimal residual disease analysis, will have in the field of AML research and treatment.